UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

Human reproduction (Oxford), 2010-03, Vol.25 (3), p.633-641

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan: integrated analysis of phase 2 asteroid 1 and 2 studies

FERTILITY AND STERILITY, 2018-09, Vol.110 (4), p.e135-e135

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan - 24-week outcomes from asteroid 2

FERTILITY AND STERILITY, 2018-09, Vol.110 (4), p.e62-e62

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of a new, low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS19.5mg) over 5 years of use: evaluation of bleeding and dysmenorrhea

Fertility and sterility, 2015-09, Vol.104 (3), p.e232-e232

2015

Link zum Volltext

Verfügbarkeit prüfen

A 12-month, Phase III study of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg) in postmenarcheal adolescents: an evaluation of placement ease and pain, bleeding and dysmenorrhea

FERTILITY AND STERILITY, 2015-09, Vol.104 (3), p.e39-e39

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

Fertility and sterility, 2009, Vol.92 (3), p.S107-S107

2009

Link zum Volltext

Verfügbarkeit prüfen

O835 Long-term experience with dienogest for the treatment of endometriosis: a one-year, open-label, follow-up study

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S332-S332

2009

Link zum Volltext

Verfügbarkeit prüfen

O301 Safety of dienogest for the treatment of endometriosis: A 24-week, randomised, open-label trial versus leuprolide acetate

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S179-S179

2009

Link zum Volltext

Verfügbarkeit prüfen

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

European journal of obstetrics & gynecology and reproductive biology, 2010-08, Vol.151 (2), p.193-198

2010

Link zum Volltext

Verfügbarkeit prüfen

Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis

Scientific reports, 2021-10, Vol.11 (1), p.20404-20404, Article 20404

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

The European journal of contraception & reproductive health care, 2004-09, Vol.9 (3), p.173-181

2004

Link zum Volltext

Verfügbarkeit prüfen

Thirty years of mirena: A story of innovation and change in women’s healthcare

Acta obstetricia et gynecologica Scandinavica, 2021-04, Vol.100 (4), p.614-618

2021

Link zum Volltext

Verfügbarkeit prüfen

Consensus on current management of endometriosis

Human reproduction (Oxford), 2013-06, Vol.28 (6), p.1552-1568

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

International journal of women's health, 2015-01, Vol.7 (default), p.393-401

2015

Link zum Volltext

Verfügbarkeit prüfen

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

Archives of gynecology and obstetrics, 2012-01, Vol.285 (1), p.167-173

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study

Advances in therapy, 2020-05, Vol.37 (5), p.2528-2537

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a New, Low-Dose Levonorgestrel Intrauterine Contraceptive System Over 5 years of Use

European journal of obstetrics & gynecology and reproductive biology, 2017-03, Vol.210, p.22-28

2017

Link zum Volltext

Verfügbarkeit prüfen

Baseline characteristics from >27,000 women with endometriosis enrolled in the VIPOS study

Fertility and sterility, 2018-09, Vol.110 (4), p.e392-e392

2018

Link zum Volltext

Verfügbarkeit prüfen

World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research

Fertility and sterility, 2014-11, Vol.102 (5), p.1223-1232

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2

European journal of obstetrics & gynecology and reproductive biology, 2020-09, Vol.252, p.7-14

2020

Link zum Volltext

Verfügbarkeit prüfen

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research

Fertility and sterility, 2014-11, Vol.102 (5), p.1213-1222

2014

Link zum Volltext

Verfügbarkeit prüfen

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research

Fertility and sterility, 2014-11, Vol.102 (5), p.1233-1243

2014

Link zum Volltext

Verfügbarkeit prüfen

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research

Fertility and sterility, 2014-11, Vol.102 (5), p.1244-1253

2014

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use” [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22–28]

European journal of obstetrics & gynecology and reproductive biology, 2019-02, Vol.233, p.164-165

2019

Link zum Volltext

Verfügbarkeit prüfen

When the Cemetery Becomes Political: Dealing with the Religious Heritage in Multi-Ethnic Regions

1, 2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(340)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(371)
Japanisch
(24)
Deutsch
(18)
Ungarisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan: integrated analysis of phase 2 asteroid 1 and 2 studies

Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan - 24-week outcomes from asteroid 2

Phase III study of a new, low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS19.5mg) over 5 years of use: evaluation of bleeding and dysmenorrhea

A 12-month, Phase III study of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg) in postmenarcheal adolescents: an evaluation of placement ease and pain, bleeding and dysmenorrhea

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

O835 Long-term experience with dienogest for the treatment of endometriosis: a one-year, open-label, follow-up study

O301 Safety of dienogest for the treatment of endometriosis: A 24-week, randomised, open-label trial versus leuprolide acetate

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

Thirty years of mirena: A story of innovation and change in women’s healthcare

Consensus on current management of endometriosis

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study

Evaluation of a New, Low-Dose Levonorgestrel Intrauterine Contraceptive System Over 5 years of Use

Baseline characteristics from >27,000 women with endometriosis enrolled in the VIPOS study

World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research

Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research

World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research

Corrigendum to “Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use” [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22–28]

When the Cemetery Becomes Political: Dealing with the Religious Heritage in Multi-Ethnic Regions

Suchergebnisse filtern